C. Lazzaro, N. A. Mazzanti, and F. Parazzini, “Severe haematological toxicities in relapsed ovarian cancer treated with olaparib or niraparib: an Italian cost-minimization analysis”, Grhta, vol. 6, no. 1, May 2019.